Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A randomized crossover study of bee sting therapy for multiple sclerosis.

T Wesselius1, D J Heersema, J P Mostert

  • 1Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands.

Neurology
|October 14, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis.

Multiple sclerosis and related disorders·2026
Same author

Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial.

Journal of the neurological sciences·2024
Same author

Longitudinal determinants of employment status in people with relapsing-remitting multiple sclerosis.

IBRO neuroscience reports·2024
Same author

Neurovisual rehabilitation in multiple sclerosis: Why a close integration of low-vision rehabilitation and neuropsychological rehabilitation may be effective for visual complaints.

Clinical rehabilitation·2023
Same author

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial.

Trials·2023
Same author

The complex relation between visual complaints and decline in visual, visuoperceptual and cognitive functions in people with multiple sclerosis.

Neuropsychological rehabilitation·2023

Bee sting therapy for multiple sclerosis (MS) did not reduce disease activity or improve disability. This study found no benefits, despite bee venom being well-tolerated in patients with relapsing MS.

Area of Science:

  • Neurology
  • Immunology
  • Complementary and Alternative Medicine

Background:

  • Bee sting therapy is a popular but unproven treatment for multiple sclerosis (MS).
  • Existing clinical evidence does not support its use for stabilizing or ameliorating MS.
  • This study aimed to investigate the efficacy of bee sting therapy in MS patients.

Purpose of the Study:

  • To evaluate the effectiveness of bee sting therapy in reducing disease activity in multiple sclerosis.
  • To assess the impact of bee sting therapy on disability, fatigue, and quality of life in MS patients.

Main Methods:

  • A randomized, crossover study involving 26 patients with relapsing-remitting or secondary progressive MS.
  • Patients received medically supervised bee sting therapy (live bees, up to 20) or no treatment for 24 weeks.

Related Experiment Videos

  • Outcomes included MRI-assessed disease activity (gadolinium-enhancing lesions, T2*-weighted lesion load), relapse rates, disability, fatigue, and quality of life.

    • Main Results:

    • Bee sting therapy did not significantly reduce new gadolinium-enhancing lesions or slow T2*-weighted lesion progression.
    • No significant reduction in relapse rate, disability, fatigue, or improvement in quality of life was observed.
    • The therapy was well-tolerated, with no serious adverse events reported.

    Conclusions:

    • Bee venom treatment for relapsing multiple sclerosis did not demonstrate efficacy in reducing disease activity.
    • The therapy did not lead to improvements in disability, fatigue, or quality of life for MS patients.
    • While safe, bee sting therapy lacks clinical support for treating multiple sclerosis based on this trial.